Bellevue Group Ag Burning Rock Biotech LTD Transaction History

Bellevue Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.75 - $10.44 $768,020 - $4.58 Million	-438,869 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.7 - $10.23 $341,840 - $521,944	-51,021 Reduced 10.41%	438,869 $4.08 Million
Q2 2021 Aug 12, 2021	BUY	$26.14 - $37.45 $1.49 Million - $2.13 Million	56,964 Added 13.16%	489,890 $14.4 Million
Q1 2021 May 12, 2021	BUY	$23.5 - $39.58 $5.82 Million - $9.8 Million	247,640 Added 133.65%	432,926 $11.7 Million
Q4 2020 Feb 16, 2021	BUY	$22.55 - $30.87 $868,738 - $1.19 Million	38,525 Added 26.25%	185,286 $4.28 Million
Q3 2020 Nov 16, 2020	BUY	$19.07 - $29.61 $1.94 Million - $3.01 Million	101,761 Added 226.14%	146,761 $3.68 Million
Q2 2020 Aug 13, 2020	BUY	$23.21 - $31.43 $1.04 Million - $1.41 Million	45,000 New	45,000 $1.22 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $589M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.